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Calcium-activated phospholipid scramblase mediates the energy-
independent bidirectional translocation of lipids across the bilayer,
leading to transient or, in the case of apoptotic scrambling, sustained
collapse of membrane asymmetry. Cells lacking TMEM16F-dependent
lipid scrambling activity are deficient in generation of extracellular
vesicles (EVs) that shed from the plasma membrane in a Ca2+-depen-
dent manner, namely microvesicles. We have adapted chemical induc-
tion of giant plasma membrane vesicles (GPMVs), which require both
TMEM16F-dependent phospholipid scrambling and calcium influx, as
a kinetic assay to investigate the mechanism of TMEM16F activity.
Using the GPMV assay, we identify and characterize both inactivating
and activating mutants that elucidate the mechanism for TMEM16F
activation and facilitate further investigation of TMEM16F-mediated
lipid translocation and its role in extracellular vesiculation.
TMEM16F | phospholipid scrambling | extracellular vesicles |
calcium influx | GPMV
Cellular membranes are composed of asymmetrically parti-tioned lipids such that certain species are sequestered to the
inner leaflet while others are exposed on the outer leaflet. Lipid
asymmetry is established and maintained by ATP-dependent
unidirectional phospholipid translocases which are colloquially
referred to as “flippases” and “floppases” (1–3). A third class of
proteins, aptly called “scramblases,” mediates bidirectional trans-
location of lipids across the bilayer in a Ca2+-activated, energy-
independent manner, which leads to a transient or, in the case of
apoptotic scrambling, sustained collapse of membrane asymmetry
(2, 4, 5). Lipid scrambling is activated in platelets during blood
coagulation, resulting in the cell surface exposure of phosphati-
dylserine (PS), a negatively charged aminophospholipid normally
sequestered on the inner leaflet of the lipid bilayer under resting
conditions (6). PS externalization provides binding sites for the
assembly of factor Xa and factor Va, which work together to
catalyze the conversion of prothrombin to thrombin, an essential
intermediary in the blood coagulation cascade (7).
Patients diagnosed with a bleeding disorder called Scott syn-
drome have platelets that are defective in lipid scrambling (8). The
molecular identity of the scramblase remained elusive until Scott
patients were discovered to harbor exon splice site mutations in the
TMEM16F gene resulting in premature termination of mRNA
translation (9, 10). TMEM16F, also known as anoctamin-6 or
Ano6, is a member of the TMEM16 family of 10 transmembrane
segment-containing proteins that are capable of forming homo-
dimers with each monomer subunit coordinating two Ca2+ ions
(11–13). This family includes founding member TMEM16A and
closely related paralog TMEM16B, which are calcium-activated
chloride channels (14, 15). By contrast, TMEM16F has been
characterized as a small-conductance Ca2+-activated nonselective
cation channel (16, 17). TMEM16F knockout mice reliably re-
capitulate the blood coagulation deficiencies observed in Scott
patients (16, 18). Furthermore, dogs with a hereditary bleeding
disorder similar to Scott syndrome also exhibit mutations in the
TMEM16F gene leading to loss of protein function (19). In addi-
tion to TMEM16F, five other members of the mammalian
TMEM16 family have been attributed with phospholipid scram-
bling activity: TMEM16C, TMEM16D, TMEM16E, TMEM16G,
and TMEM16J (20, 21). Furthermore, lipid scrambling activity is
exhibited by fungal TMEM16 homologs from Nectria haemato-
cocca and Aspergillus fumigatus that are reconstituted into lipo-
somes (11, 22) and mouse TMEM16F isolated in a lipid bilayer
microarray (23), suggesting that TMEM16 proteins may be directly
responsible for scramblase activity.
Cells lacking TMEM16F-mediated lipid scrambling activity are
also deficient in microvesicle generation in humans (8, 24) and in
mice (18, 25, 26), although it is not well understood how scrambling
relates to vesiculation. Microvesicles are a subset of extracellular
vesicles (EVs) that have also been referred to as “microparticles”
or “ectosomes” in the literature. They distinctively shed from the
plasma membrane in a Ca2+-dependent manner and range in size
from 100 nm to 1 μm in diameter depending on the cell type of
origin (27, 28). EVs are thought to carry bioactive cargo in the form
of RNAs, proteins, and/or lipids which can elicit biological activity
in other cells in either a short-range or long-range manner (27, 28).
Platelet microvesicles are one of the earliest reported examples of
EVs; they were first biochemically purified as procoagulation activity
in a cell-free fraction (29) and then demonstrated by electron mi-
croscopy to be membrane-bound vesicles (30). TMEM16F-dependent
EVs have also been implicated in the anti-inflammatory properties
of neutrophils in joint inflammation (26), mineral deposition
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during bone development (25), and modulating T cell receptor
signaling (31, 32).
Quantification of extracellular vesicles using conventional tech-
niques is challenging due to the inherent difficulties of resolving
particles on a nanoscale. Here we use chemically induced giant
plasma membrane vesicles (GPMVs) to investigate the role of
TMEM16F phospholipid scrambling activity in extracellular vesic-
ulation. Due to their enlarged dimensions, GPMVs can be moni-
tored in real time by conventional light microscopy, revealing that
vesiculation depends on TMEM16F-mediated lipid scrambling and
vesicle formation begins after the initiation of PS exposure. Strik-
ingly, we find these giant vesicles to robustly depend on Ca2+ acti-
vation of TMEM16F and TMEM16F-dependent Ca2+ entry. Using
the GPMV assay, we identify and characterize both inactivating and
activating TMEM16F mutants in kinetic analyses that facilitate
further investigation of TMEM16F-mediated lipid translocation and
extracellular vesicle formation.
Results
TMEM16F-Deficient Cells Have Impaired Ability to Generate GPMVs.
GPMVs are chemically induced to form blebs from cultured cells
using sulfhydryl blocking reagents such as formaldehyde,
N-ethylmaleimide, and iodoacetamide (33, 34). Similar to
microvesicles, they are shed from the plasma membrane, are
dependent on calcium, and expose PS on the vesicle surface (33–35).
More recently, GPMVs have been demonstrated to segregate into
micrometer-scale lipid raft-like domains and have proven useful for
the study of membrane phase separation (36, 37).
To assess whether the GPMV assay could be used as a tool for
studying the role of TMEM16F in vesiculation, we first asked
whether production of these giant vesicles was dependent on ex-
pression of the TMEM16F protein. We cultured primary mouse
embryonic fibroblasts (MEFs) from wild-type (WT), TMEM16F
heterozygotes (16FHet), and knockout (16FKO) mouse embryos and
induced vesiculation using extracellular solution containing 25 mM
paraformaldehyde (PFA), 2 mM DTT, and 2 mM CaCl2. WT
MEFs robustly produced GPMVs which terminated production
about 60 min posttreatment; by contrast, 16FHet and 16FKO MEFs
exhibited resistance to GPMV formation posttreatment (Fig. 1A
andMovies S1–S3). We did not observe vesicles produced by 16FHet
cells until 90 min posttreatment, and the vesicle diameter was
smaller than that of WT. The 16FKO cells completely failed to
vesiculate within the time allotted for the experiment. Western blot
analysis indicated that 16FHet MEFs express TMEM16F protein at
about 50% of the normal level and confirmed that 16FKO MEFs
lack TMEM16F expression (Fig. 1B).
Next, we performed proteomics to compare the protein com-
positions of GPMVs and microvesicles. In addition to primary
MEF cells, GPMVs were successfully induced in many cell types,
including microglial cell line BV2 and melanoma cells B16F10 but
not HEK293 cells (SI Appendix, Fig. S1A). We performed shotgun
proteomic experiments to identify proteins found in GPMVs iso-
lated from three mouse cell lines (primary MEFs, B16F10, and
BV2) as well as microvesicles purified from calcium ionophore
activated mouse platelets (SI Appendix, Fig. S1B and Dataset S1).
We found 750 proteins that were in common among the three
GPMV samples, representing 56, 53, and 73% of total proteins
assigned in MEF, B16F10, and BV2 GPMVs, respectively. Of
these shared GPMV proteins, 191 proteins were also found to be
in common with proteins identified from platelet microvesicles.
We reasoned that this overlapping set of proteins among all four
EV samples might represent a core complement of proteins re-
quired for EV biogenesis regardless of the cell type of origin.
Using the gene ontology term “extracellular exosome” (GO:
0070062), we generated a list of 2,620 EV-related genes in the
mouse genome and converted the mouse genome informatics
(MGI) identifiers to 10,802 UniProtKB IDs. Of the 191 proteins
found in common from extracellular vesicles of all four cell types,
167 (or 87%) were annotated as potential EV proteins. This is a
fourfold enrichment over the expected baseline percentage of
21% (10,802 out of 51,434 total proteins in the UniProt database,
February 2018) and has a two-tailed P value of <0.0001 calculated
using a χ2 test with Yates correction. Because GPMVs resemble
microvesicles not only in their dependence on calcium and
TMEM16F but also in their protein composition, we next tested
whether TMEM16F expression in HEK293 cells can confer the
ability of GPMV formation to establish a platform for assessing
the dependence of EV formation on various aspects of TMEM16F
functions in mutagenesis studies.
Overexpression of TMEM16F in HEK293 Cells Confers Ability to Produce
GPMVs. Having found that HEK293 cells exhibited resistance to
vesiculation, we performedWestern blot and observed that HEK293
cells expressed much lower levels of endogenous TMEM16F protein
than GPMV-competent cell types (SI Appendix, Fig. S1C). To test
whether overexpression of TMEM16F in HEK293 cells might confer
the ability of HEK293 cells to respond to chemically induced ve-
siculation, we used lentivirus to generate a stable HEK293 cell line
that expressed mouse TMEM16F tagged on the C terminus with
mCherry (16F-mCh). TMEM16F expression in these cells is local-
ized primarily to the plasma membrane, whereas the control cell
line, expressing cytoplasmic mCherry (mCh-cyto), showed diffuse
mCherry signal in the cytosol (Fig. 2A). Because mCh-cyto fluoresces
brighter under the microscope than 16F-mCh, we expressed it using
a weaker PGK promoter, which led to ∼20-fold less protein ex-
pression than 16F-mCh driven by a CMV promoter. Such discrep-
ancy in protein expression level is reflected in the Western blot
analysis using an mCherry antibody, whereby longer exposure time is
needed to detect the mCh-cyto signal than that of 16F-mCh re-
gardless of their comparable fluorescence signals visualized under
microscopy (Fig. 2B). Overexpression of TMEM16F was indeed
capable of conferring the ability to generate GPMVs to previously
unresponsive HEK293 cells (Top Row in Fig. 2C and Movie S4). By
contrast, mCh-cyto cells remained resistant to GPMV induction
(Bottom Row in Fig. 2C and Movie S5), a condition similar to
untransfected HEK293 cells. From these time-lapse images, we
quantified GPMV production by 16F cells using an edge detection
algorithm to count newly formed vesicles (SI Appendix, Fig. S2) and
observed that the increase in GPMVs with time was sigmoidal (Fig.
2D), with a delay in GPMV onset of 24.2 ± 0.6 min, a growth phase
of GPMV formation lasting 14.2 ± 0.2 min with a maximum vesic-
ulation rate (Vmax) of 0.1 ± 0.01 GPMVs per cell/min, and a ter-
mination in GPMV formation after 38.3 ± 0.6 min resulting in an
average of 2.3 ± 0.2 GPMVs formed per cell (Fig. 2E). Time of
BA
Fig. 1. TMEM16F-deficient MEF cells show impaired GPMV generation. (A)
Wild type (WT), TMEM16FHet (Het), and TMEM16FKO (KO) primary MEFs are
treated with 25 mM PFA and 2 mM DTT in a 2-mM Ca2+ buffer to induce
GPMVs. WT MEFs show robust vesiculation after 90 min of treatment (white
arrows), while TMEM16FHet MEFs exhibit a diminished vesiculation response.
TMEM16FKO MEFs do not yield GPMVs within 90 min. (Scale bars: 50 μm.) (B)
Western blot analysis of endogenous TMEM16F protein expression in WT
and TMEM16F-deficient cells. The asterisk (*) denotes a nonspecific band;
α16F, α-TMEM16F; α-Tub, α-tubulin.
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onset, Vmax, and duration could not be determined for mCh-cyto
cells since they do not visibly vesiculate within the allotted time.
GPMV Generation Depends on TMEM16F-Mediated Lipid Scrambling
Activity. Having found that TMEM16F was required for the genera-
tion of GPMVs and sufficient to restore vesiculation to HEK293 cells,
we wondered whether this was due to TMEM16F-dependent lipid
scrambling activity. Through analysis of divergent sequences between
TMEM16F (16F) and its nonscrambling paralog TMEMF16A (16A),
a stretch of 35 amino acids [scrambling domain (SCRD)] was identified
in TMEM16F that appeared to confer scrambling activity to
TMEM16A when analogous residues were swapped (38). We
wondered whether the scrambling-competent “AFA” chimera, a
TMEM16A protein harboring the TMEM16F SCRD, could re-
capitulate the ability of TMEM16F to produce GPMVs in HEK293
cells and, likewise, whether the scrambling-deficient “FAF” chi-
mera, which harbors the reciprocal swap in TMEM16F, and the
nonscrambling TMEM16A would exhibit deficits in vesiculation.
We generated stable HEK293 cell lines expressing the AFA chi-
mera, the FAF chimera, and TMEM16A tagged with C-terminal
mCherry. Consistent with our hypothesis that GPMV generation
was dependent on lipid scrambling, AFA expression was indeed able
to confer vesiculation capability to HEK293 cells with no significant
delay (Fig. 3 A and D), although reaching a diminished magnitude
compared with 16F cells, producing on average 0.8 ± 0.2 vesicle per
cell (Fig. 3B), and at a slower maximal rate, about 20% relative to
16F (Fig. 3C). By contrast, stable cell lines expressing the scrambling-
deficient FAF or the nonscrambling 16A failed to vesiculate, similar
to mCh-cyto and untransfected HEK293 cell lines.
Next, we verified that GPMV treatment induced lipid scram-
bling. It has been previously shown that PFA induces PS expo-
sure in platelets (39), a cell type where TMEM16F-dependent
vesiculation has been extensively characterized, and HeLa-
P4 cells (40). We used pSIVA, an annexin-based reagent that
fluoresces when bound to externalized PS, to indicate activation
of lipid scrambling. Indeed, PS exposure is robustly induced in
both 16F cells (Fig. 3E, First Row) and AFA cells (Fig. 3E, Third
Row). By contrast, application of PFA fails to expose PS in cells
expressing nonscrambling 16A (Fig. 3E, Second Row) and mCh-
cyto cells (Fig. 3E, Fifth Row). As expected, FAF cells are de-
fective in PFA-induced scrambling (Fig. 3E, Fourth Row); how-
ever, the expression of this chimera construct is weak on the
A
C
D E
B
Fig. 2. TMEM16F overexpression endows HEK293 cells with the capacity for GPMV generation. (A) Exogenously expressed TMEM16F-mCherry (16F) is pri-
marily localized to the plasma membrane and it colocalizes with eGFP-PH-PLCδ, a genetically encoded phosphatidylinositol-(4, 5)-bisphosphate (PIP2) sensor
used to demarcate the cell membrane. (B) Western blot analysis showing the level of TMEM16F-mCherry (16F) and mCh-cyto overexpression in HEK293 stable
cell lines. Different exposure times are displayed for 16F and mCh-cyto bands due to disparate protein levels. (C) HEK293 cells stably expressing either
TMEM16F-mCherry (16F-mCh) or mCh-cyto are chemically induced to generate GPMVs. GPMV generation is robustly induced in 16F-mCh cells (white arrows,
Top Row), but mCh-cyto cells show no sign of vesiculation after 60 min of treatment (Bottom Row). (D) Quantification of GPMV generation during 1-h time
course. (E) Average number of vesicles counted per cell after 1 h of GPMV induction. P < 0.0001 by unpaired two-tailed t test. (Scale bars: A, 10 μm; C, 50 μm.)
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plasma membrane compared with 16F and AFA, so the resulting
deficiency may be an overestimation. Quantification of average
pSIVA fluorescence over the 1-h time course (Fig. 3F) reveals that
although AFA cells achieve a maximal level of pSIVA fluores-
cence similar to that of 16F cells (Fig. 3G), they appear to
scramble at a faster rate (Fig. 3H) and have an onset time of 8.4 ±
3.2 min after stimulation, which is about 10 min faster than 16F
scrambling occurring at 17.1 ± 4.9 min. FAF cells, on the other
hand, exhibit overall reduced pSIVA accumulation (Fig. 3G), a
diminished rate of scrambling (Fig. 3H), and, most strikingly, a
20-min delay in the onset of scrambling at 39.9 ± 7.6 min (Fig. 3I).
Both 16A and mCh-cyto cells show minimal, if any, pSIVA
binding (Fig. 3G), which strongly correlates with their deficiency in
vesiculation. These results demonstrate that not only do cultured
cells require lipid scrambling to successfully generate GPMVs but
TMEM16F-dependent lipid scrambling may be required for op-
timal induction. Furthermore, the timing of scrambling onset ap-
pears to be a critical parameter in GPMV formation.
GPMV Generation Requires Calcium Activation of TMEM16F. Experi-
mental evidence from functional and structural studies of
TMEM16A (12, 13, 45) and the fungal homolog nhTMEM16
(11) suggests that the calcium-binding site on each monomer
subunit is composed of six amino acids found on transmembrane
helices 6–8 (TM6–TM8) and is predicted to coordinate two Ca2+
ions. These residues are conserved in TMEM16F: N620 and
E624 on TM6, E667 and E670 on TM7, and E699 and D703 on
TM8 (Fig. 4 A and B). Of these, only E667 has been confirmed
A
E
F G H I
B C D
Fig. 3. GPMV generation requires TMEM16F-mediated lipid scrambling. (A) Quantification of the average number of GPMVs generated per cell over a time-
lapse series. Scatter dot plots showing (B) the average number of GPMVs generated per cell by each cell line after 1 h of incubation, (C) maximum rate of
vesiculation expressed as fold change relative to 16F, and (D) onset of GPMV formation. (E) Stable cell lines expressing wild-type TMEM16F-mCherry (16F),
wild-type TMEM16A-mCherry (16A), TMEM16F::TMEM16A chimeras (AFA and FAF), and mCh-cyto are chemically induced to vesiculate for 1 h in the presence
of pSIVA, a polarity-sensitive fluorescent PS binding reagent. At 0 min, cells are depicted as an overlay of mCherry (magenta), pSIVA (green), and Hoechst
nuclear stain (blue). For all other time points, the mCherry channel is omitted for clarity. Representative images are shown. (Scale bars: 10 μm.) (F) Quan-
tification of pSIVA fluorescence normalized to mCherry signal per cell over a time-lapse series. Scatter dot plots showing (G) the maximum pSIVA signal per
cell expressed as fold change (FC) relative to 16F, (H) Vmax of pSIVA accumulation, and (I) onset of pSIVA fluorescence. Statistical significance of all mutants
compared with 16F wild type determined by one-way ANOVA followed by a Holm–Sídák multiple comparisons test for B, G, H, and I. Statistical significance
was determined by an unpaired two-tailed t test for C and D; ns, not significant.
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experimentally in TMEM16F to alter Ca2+ sensitivity in current
activation (16). We stably expressed TMEM16F-mCherry bearing
point mutations in each calcium-binding residue in HEK293 cells
to test their role in GPMV generation. Cell lines bearing a charge-
neutralizing mutant for four of the five acidic residues (E667Q,
E670Q, E699Q, and D703N) fail to vesiculate within 1 h (Fig. 4 C
and D), similar to 16A, mCh-cyto, and untransfected HEK293
cells. Cells expressing a charge-neutralizing mutant for the fifth
acidic residue (E624Q) demonstrated the capacity to vesiculate
but exhibited a considerably diminished response, averaging 0.4 ±
0.03 vesicle per cell, or 18% that of WT 16F. The N620A mutant,
on the other hand, led to mild, although statistically significant,
deficiencies in GPMV generation, producing, on average, 1.5 ±
0.3 vesicles per cell, ∼70% that of WT 16F.
We next performed live cell imaging with pSIVA to assess
whether deficient vesiculation corresponded to defective scram-
bling activity. Consistent with predictions, cells expressing the
vesiculation-dead E667Q mutant did not externalize PS following
GPMV treatment, whereas the partially defective E624Q mutant
led to a delay in scrambling onset and greatly diminished magni-
tude of PS externalization (Fig. 4 E and F). Interestingly, cells
expressing the N620A mutant showed no indication of scrambling
deficiency compared with wild type, instead exhibiting a slightly
augmented maximal response, suggesting that their moderate re-
duction in vesiculation may be due to a mechanism independent
of PS translocation. Finally, we tested the channel activity of these
calcium-binding mutants and found that E667Q has an EC50 at
23.2 ± 9.4 mM, about a 4,000-fold reduction in Ca2+ sensitivity
compared with that of WT 16F, 5.5 ± 0.6 μM, which is consistent
with previously reported data (16). Both N620A and E624Q show
moderate right shifts with EC50s of 12.0 ± 4.2 μM and 18.8 ±
3.3 μM, respectively (Fig. 4 G and H), which correlate well with
partial reduction of activity in the vesiculation assay.
Mutating Predicted Pore-Lining Residues on TM6 Promotes TMEM16F
Activity. Pore-lining residues were identified on TM6 of TMEM16A
that, when substituted with alanine, led to a channel prone to ac-
tivation at lower concentrations of Ca2+ (41). We generated mutant
constructs to analogous residues in TMEM16F (I612, G615, and
K616) with the prediction that they might also accelerate lipid
translocation due to heightened Ca2+ sensitivity. These residues are
not strictly conserved in the extended TMEM16 family and may
represent a more specialized function in mammalian TMEM16
proteins. Although the fungal TMEM16 homologs have a hydro-
phobic phenylalanine at the I612 position, G615 and K616 of
TMEM16F are not conserved at all in fungal homologs (Fig. 5A).
Since I612 is predicted to contribute bulk and/or hydrophobicity to
the putative pore region, in addition to mutating it to alanine, we
further substituted it with either valine or threonine, which are
similar in bulk but have different hydrophobicity, to distinguish
between the two factors. TMEM16A cryo-EM structures suggest
that TM6 bends or flexes at G615 (12, 13), which modulates the
diameter of the hydrophilic groove that is considered the pore for
ion conductance (Fig. 5B). In addition, it has also been suggested
that upon Ca2+ activation, two calcium-binding residues, N620 and
E624, that reside on the lower half of TM6 are recruited to the Ca2+
binding pocket, causing TM6 to swing outward, further dilating the
pore (12, 13). We expected that alanine mutation of G615 would
enforce rigidity upon this predicted hinge region in TM6. Moreover,
mouse TMEM16F has an additional glycine at position 614 not
found in TMEM16A, so we also mutated it to alanine and gener-
ated a double G614A/G615A (GAGA) for analysis. Last, we gen-
erated K616 mutants that either neutralized (K616A, K616Q) or
reversed the charge (K616E) of this critical residue.
We chemically induced vesiculation in cells stably expressing
TMEM16F with these mutations and found that although only
the K616 mutants showed an increase in the total number of
GPMVs generated (Fig. 5 E and F), all of the activating mutants
had accelerated time to onset for GPMV formation (Fig. 5G).
Cells expressing the K616E mutant produced the greatest
number of vesicles in this study (2.9 ± 0.1 GPMVs per cell) and
exhibited the fastest measured time to vesiculation (11.3 ±
0.8 min). The cell lines expressing the other two K616 mutants,
K616A and K616Q, followed closely with 2.6 ± 0.1 and 2.5 ± 0.1
GPMVs produced per cell with onset times of 11.8 ± 0.8 min and
15.7 ± 0.8 min, respectively. The I612A mutant had the third
fastest GPMV onset time of 14.8 ± 0.6 min (Fig. 5C). I612T
retained the activating effect of I612A, with a GPMV onset of
19.9 ± 0.4 min, whereas I612V was slightly slower than WT, with
an onset time of 26.7 ± 0.8 min, suggesting that the mechanism
A
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Fig. 4. TMEM16F calcium-binding mutants show deficiency in vesiculation.
(A) Amino acid alignment depicting the six predicted calcium-binding residues
in TMEM16F: N620 and E624 on TM6, E667 and E670 on TM7, and E699
and D703 on TM8. All acidic residues are conserved among nonscrambling
TMEM16A and the fungal TMEM16 homologs nhTMEM16 and afTMEM16. (B)
Close-up view of the calcium-binding site in a TMEM16F homology model.
Calcium ions are represented as green spheres. (C) Quantification of GPMV
generation by HEK cell lines stably expressing TMEM16F-mCherry with muta-
tions in each calcium-binding residue. (D) Scatter dot plot showing the average
number of GPMVs produced per cell after 1 h. (E) Quantification of average
pSIVA fluorescence normalized to mCherry from time-lapse images. (F) Scatter
dot plot showing the maximal pSIVA fluorescence per cell. (G) Electrophysio-
logical recordings showing right shift of Ca2+ sensitivity by calcium-binding
mutants. (H) Scatter dot plot showing average EC50 values for Ca
2+ gating.
Statistical significance was determined for all mutants compared with 16F wild
type by one-way ANOVA followed by a Holm–Sídák multiple comparisons test
for D and F. Significant differences for EC50s of Ca
2+ response curves of mu-
tants compared with 16F wild type were determined with Kruskal–Wallis tests
followed by Dunn’s multiple comparison tests. In F and H, ns indicates not
significant.
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of activation depends on decreasing hydrophobicity rather than
reducing steric hindrance. Mutation of the first TM6 glycine in
mouse TMEM16F (G614A) led to a diminished and delayed
vesiculation response, but mutation of the second glycine
(G615A), which is conserved in TMEM16A, had an accelerated
vesiculation onset time of 15.2 ± 0.8 min, although producing a
similar number of total vesicles as wild type (Fig. 5D). In-
terestingly, the double glycine mutant (GAGA) appears to re-
store WT kinetics with a slight decrease in magnitude. From
these data, we conclude that G615 corresponds to the glycine
hinge described for TMEM16A and alanine substitution at this
position either accelerates the transition kinetics or stabilizes the
straightened helix present when the pore is fully open.
We found that consistent with our GPMV data, I612A,
G615A, and K616A mutants also promoted lipid scrambling
(Fig. 5H). These activating effects were apparent in the increase
of the maximal amplitude of pSIVA accumulation (Fig. 5I) due
to an accelerated Vmax (Fig. 5J). We also found that, similar to
A
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Fig. 5. Activating mutants on TM6 promote GPMV generation. (A) Alignment of TM6 helices reveals variations at positions I612, G615, and K616. (B)
Structural view of TM6 residues within the context of the hydrophilic groove and the calcium-binding site. (C) Quantification of GPMV generation for
I612 mutants that either eliminates the bulky, hydrophobic side chain (I612A), slightly reduces the hydrophobicity (I612V), or greatly reduces hydrophobicity
(I612T). (D) Quantification of GPMV generation for alanine mutants that reduce the flexibility of G615 (G615A), neighboring G614 (G614A), or the double
G614A/G615A (GAGA) mutant. (E) Quantification of GPMV generation for K616 mutants that either neutralize the charge (K616A and K616Q) or reverse the
charge (K616E). (F) Scatter dot plots showing the average number of GPMVs produced after 1 h of incubation and (G) the average time to onset for ve-
siculation. (H) Quantification of pSIVA fluorescence normalized to mCherry from time-lapse images. Scatter dot plots showing (I) the maximal pSIVA fluo-
rescence per cell and (J) the maximal rate of pSIVA accumulation per cell. (K) Scatter dot plot obtained from electrophysiological recordings showing the
increase of Ca2+ sensitivity by TM6 activating mutants. Statistical significance of all mutants compared with 16F wild type was determined by one-way ANOVA
followed by a Holm–Sídák multiple comparisons test for F, G, I, and J. Significant differences for EC50s of the Ca
2+ response curves of mutants compared with
16F wild type were determined with Kruskal–Wallis tests followed by Dunn’s multiple comparison tests. In F ns indicates not significant.
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TMEM16A (41), these mutations all shift the TMEM16F Ca2+
binding curve to the left, with EC50s on average 2–3 μM less than
WT (Fig. 5K). However, the EC50 values do not recapitulate the
trend exhibited by these mutants in the GPMV generation assay,
suggesting that heightened sensitivity to Ca2+ only partially ac-
counts for increased activity.
Mechanism of Calcium Activation in GPMV Generation. Because
both microvesicle production and TMEM16F activation are
Ca2+-dependent, we next investigated whether cellular exposure to
PFA leads to an intracellular Ca2+ rise and whether that might also
underlie GPMV generation. To measure Ca2+ levels, we loaded cells
with green fluorescent Ca2+ reporter dye Fluo-5N before chemical
induction of vesiculation. Upon inducing GPMV formation, we
observed that vesiculation is indeed robustly correlated with a Ca2+
rise in cells expressing either WT TMEM16F or the activating
K616A mutant, while nonvesiculating cells expressing either
mCherry-tagged TMEM16F calcium-binding mutant E667Q or
mCh-cyto alone experienced a severely diminished Ca2+ response to
PFA (Fig. 6 A and B). The onset time for Ca2+ rise for 16F cells was
observed to be 22.9 ± 0.7 min, which slightly preceded the onset of
GPMV generation (Fig. 6C). Furthermore, cells bearing the K616A
mutant exhibited accelerated Ca2+ increase with a time to onset of
4.3 ± 0.6 min as estimated by curve modeling, although data col-
lected began 10 min posttreatment. Unexpectedly, the magnitude of
Ca2+ response was decreased compared with WT, perhaps due to
weaker overall expression levels of the mutant construct.
Next, we investigated the source of Ca2+ required for GPMV
generation. Upon repeating the GPMV assay with 16F cells
without calcium in the external solution (0Ca), we observed
minimal increase in Ca2+ levels (Fig. 6D) and no vesiculation (Fig.
6E), indicating that both are dependent on extracellular Ca2+.
Interestingly, by titrating increasing amounts of buffer [Ca2+], we
observed a concentration-dependent effect on both intracellular
Ca2+ levels (Fig. 6D) and GPMV generation (Fig. 6E), suggesting
that influx of external Ca2+ is required for vesiculation in this
assay. We also employed various pharmacological interventions to
manipulate the GPMV-associated Ca2+ rise. As expected, treat-
ment with intracellular Ca2+ chelator BAPTA-AM [1,2-Bis(2-
aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxy-
methyl ester)] suppressed both intracellular Ca2+ (Fig. 6D) and
GPMV generation (Fig. 6E), confirming that intracellular Ca2+
accumulation is essential for vesiculation. We administered 2-
aminoethoxydiphenyl borate (2-APB) concurrently with PFA to
block store-operated Ca2+ entry in cells undergoing GPMV gen-
eration. Conventionally, a low concentration (<10 μM) of 2-APB
is used to block store-operated Ca2+ entry through inositol
trisphosphate receptor inhibition, but at higher doses, 2-APB has
been shown to affect Ca2+ channels on the plasma membrane
(42). In the GPMV assay, 5 μM 2-APB led to partial inhibition of
both Ca2+ influx, and 50 μM 2-APB completely abolished Ca2+
response to PFA treatment (Fig. 6D) and led to a dose-dependent
reduction of GPMV production (Fig. 6E). Taken altogether, these
experiments reveal a robust linear correlation (r2 = 0.9807) between
intracellular [Ca2+] and GPMV response (Fig. 6E). We have fur-
ther used nanoparticle tracking to analyze extracellular vesicles
within physiological size range and found that vesiculation either by
calcium ionophore A23187 or with the chemical induction protocol
for GPMV formation shows a similar dependence on TMEM16F
function (SI Appendix, Fig. S4). From these data, we conclude that
influx of extracellular Ca2+ was primarily responsible for the sus-
tained Ca2+ rise experienced by cells undergoing vesiculation and
that successful induction of GPMV formation requires accumu-
lation of intracellular calcium and TMEM16F activation.
Discussion
We have developed a robust and quantitative assay for assessing
TMEM16F activity by using GPMVs, chemically induced giant
vesicles that bud from the plasma membrane. Due to their in-
herently larger size, they are visible under conventional light
A
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Fig. 6. GPMV treatment induces TMEM16F-dependent intracellular calcium rise. (A) HEK293 cells stably expressing either TMEM16F-mCherry (16F), mCh-
cyto, calcium-binding mutant E667Q, or activating mutant K616A are preloaded with calcium reporter dye Fluo-5N (green) and chemically induced to
generate GPMVs. (Scale bars: 25 μm.) (B) Quantification of calcium reporter dye over time-lapse series. P < 0.001 by unpaired two-tailed t test. (C) Scatter dot
plot showing the onset of Ca2+ flux. (D) Quantification of calcium reporter dye during GPMV induction under different Ca2+ manipulations. (E) Scatterplot
showing the correlation between intracellular Ca2+ levels and GPMV generation.
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microscopy and thus can be monitored in real time. Before our
study, it was understood that GPMV generation was a Ca2+-
dependent process that produced PS-exposing vesicles which
were enriched in cholesterol and sphingolipids (34) and capable
of membrane phase separation reminiscent of lipid rafts (35, 36,
43, 44). We further demonstrated that vesiculation was robustly
dependent on TMEM16F expression in primary MEF cells in a
dose-dependent manner (Fig. 1) and that exogenous expression
of TMEM16F-mCherry (16F) protein successfully conferred the
ability to produce GPMV toHEK293 cells (Fig. 2). Since under these
conditions, untransfected HEK293 cells behave like TMEM16F
KO cells, we were therefore able to use it as a platform for
probing TMEM16F function.
We found that GPMV generation requires TMEM16F-
mediated lipid scrambling activity (Fig. 3 A and B). Cells that
were scrambling-deficient (16A, mCh-cyto, FAF chimera) were
either poor vesiculators or unable to vesiculate within the allotted
time. The scrambling-competent AFA chimera, however, was able
to substitute for TMEM16F expression to produce GPMVs. In-
terestingly, although AFA cells showed a faster onset of scrambling
compared with 16F cells, they yielded only about a third of GPMVs
produced by WT 16F. There are several possible scenarios to ac-
count for these observations. First, since the AFA construct is
primarily composed of the TMEM16A protein sequence with the
exception of 35 amino acids from TMEM16F, it is possible that the
accelerated onset is due to TMEM16A being more sensitive to
Ca2+ with an EC50 of 0.5–1 μM (12, 45). A second explanation for
why AFA cells vesiculated poorly might be that TMEM16F pos-
sesses other biophysical characteristics or features important for
vesiculation that are absent in TMEM16A and, by extension, the
AFA chimera. While activating mutants that promote GPMV ve-
siculation (i.e., I612A, G615A, and K616A) exhibited enhanced
lipid scrambling response (Fig. 5 H–J), we also observed that the
FAF chimera and the E624Q mutant, which are vesiculation-
deficient, are still capable of exposing PS to the extracellular
leaflet in response to application of PFA (Figs. 3F and 4E). This
finding perhaps indicates that vesiculation has heightened re-
sponsiveness to mild scrambling deficits. Since lipid scrambling
appears to be a prerequisite for vesiculation, this makes the GPMV
assay a more sensitive, albeit indirect, reporter of scrambling ac-
tivity. It also supports the hypothesis that TMEM16F has broader
functions in extracellular vesicle generation, including, but not
limited to, its capacity as a calcium-activated lipid scramblase.
Using the GPMV assay, we experimentally validated the im-
portance of six predicted calcium-binding residues for TMEM16F
located on TM6 (N620, E624), TM7 (E667, E670), and TM8
(E699, D703). Four of the five acidic residues (E667Q, E670Q,
E699Q, D703N), when replaced with charge-neutralizing amino
acids, abolished GPMV generation, while N620A and E624Q
exhibited less severe deficiencies (Fig. 4 C andD). The vesiculation-
dead mutant E667Q did not expose PS in response to GPMV
treatment, and E624Q displayed severe scrambling deficiencies
(Fig. 4 E and F). N620A, on the other hand, appeared to expose
PS as well as or better than WT 16F. Interestingly, E650 in
TMEM16A, which corresponds to E624 in TMEM16F, has been
shown to coordinate Ca2+ in a manner that does not depend on its
charge (45), setting TM6 calcium-binding residues apart from the
other four. Based on TMEM16A structural studies, we surmised
that the calcium-binding residues on TM7 and TM8 might be
responsible for coordinating the first Ca2+ (12). Following the
initial binding, TM6 experiences a conformational change that
allows the calcium-binding residues on TM6 to help coordinate
the second Ca2+ (12, 13, 41). This perhaps indicates that the co-
ordination of the second Ca2+ is not an absolute requirement for
GPMV formation and may explain why, unlike E667Q, both
N620A and E624Q show a moderate increase in their EC50 for
Ca2+ (Fig. 4H) and are still capable of calcium-activated lipid
scrambling (Fig. 4E). In addition, additional asparagines were
implicated in Ca2+ binding, which may also explain the mild deficit
of N620A in GPMV generation (13).
Quantification of GPMV generation from TMEM16F-
overexpressing HEK293 stable cell lines shows a sigmoidal-like
curve with a delay in onset of about 24 min, with a duration of
16 min before plateauing around 40 min posttreatment. PS ex-
posure and calcium influx precede the onset of GPMV formation,
which has also been shown previously in HeLa-P4 cells (40), and
both appear to be required for vesiculation. Given the timing of
these events, we suspect that the delay in the onset of GPMV
formation is dependent on achieving a certain threshold of in-
tracellular Ca2+ for scrambling activation. Furthermore, because
the activating mutants on TM6 appear to generate GPMVs for a
longer period of time than wild-type TMEM16F (SI Appendix, Fig.
S3), we speculate that termination of GPMV generation may be
due to an intrinsic property of TMEM16F, such as desensitization
of TMEM16F due to exposure to high Ca2+ (17), rather than a
property of the cell such as insufficient lipids for formation of
additional vesicles or the equilibration of PS across the bilayer.
Based on our current understanding of Ca2+mobilization under
GPMV induction, we believe that cellular exposure to PFA leads
to a small Ca2+ rise, enough to activate TMEM16F, which in turn
induces a sigmoidal-like, sustained Ca2+ rise that is dependent on
extracellular Ca2+. The exact mechanism for GPMV-associated
Ca2+ influx is unknown, but it appears to be sensitive to in-
hibition by 2-APB and tightly correlated with TMEM16F activity.
One possibility is that TMEM16F, being a Ca2+-activated cation
channel (16), may itself contribute to Ca2+ entry. Indeed, re-
searchers have speculated whether cation conductance may be
utilized as a counter ion to balance lipid translocation (46), but
further investigation would be necessary to test this scenario.
GPMVs are generated using sulfhydryl-blocking reagents such
as formaldehyde and N-ethylmaleimide (33, 34). In this study, we
used 25 mM PFA and 2 mM DTT. Supplementation with DTT
was found to allow for a 25% reduction of PFA concentration
necessary for GPMV formation by unknown mechanisms, thus
limiting potential cellular toxicity (35). On a practical note, our
experiments demonstrate that caution may be warranted when
subjecting any TMEM16F-expressing cells to chemical fixation.
Treatment of our stable HEK293 cell lines with 4% PFA (1.3 M)
triggers robust GPMV generation within minutes, which not only
distorts cellular morphology but also causes intracellular Ca2+
rise, potentially compromising downstream analyses.
In summary, we have demonstrated that chemically induced
GPMVs are robustly dependent on TMEM16F-mediated lipid
scrambling and can be used as a vesiculation-based assay for
TMEM16F activity. The role that lipid scrambling plays in gen-
eration of extracellular vesicles is not well understood, although
some potential functions include disruption of lipid–protein in-
teractions and modulation of membrane curvature. GPMV
generation as a model vesiculation system may prove to be useful
in future studies to gain understanding of the precise utility of
scrambling in this biological process as well as other potential
TMEM16F functions required for extracellular vesiculation.
Materials and Methods
Cell Culture and Cloning.
Primary MEF culture. Embryonic fibroblasts were harvested from mouse em-
bryos E12–E16 from TMEM16F Het × Het matings. Each embryo was pro-
cessed separately and genotyped at a later date. Tissue was triturated by
vigorous pipetting following trypsinization and plated in a six-well plate.
Stable HEK293 cell lines.Wild-type and mutant TMEM16F-mCherry, TMEM16A-
mCherry, and cytoplasmic mCherry were subcloned into pENTR1A (Addgene
plasmid 17398) and transferred to pLenti CMV Hygro DEST (Addgene plasmid
17454) or pLenti PGK Hygro DEST (Addgene plasmid 19066) using Gateway
cloning (Thermo Fisher). Note that the first three amino acids of TMEM16F
have been truncated to facilitate expression, but residue numbering is based
on full-length reference sequence. pENTR1A no ccDB (w48-1), pLenti CMV
Hygro DEST (w117-1), and pLenti PGK Hygro DEST (w530-1) were gifts from
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Campeau et al. (47). Lentiviral constructs were cotransfected into
HEK293FT cells with packaging plasmids pMD.2G and psPAX2, which were
gifts from Didier Trono (Addgene plasmids 12259 and 12260). Lentivirus was
harvested from the transfected cells 36–48 h posttransfection, mixed with
8 μg/mL polybrene, and incubated with HEK293 cells to establish stable cell
lines under hygromycin selection. All cells (except cytoplasmic mCherry) were
verified by microscopy to express mCherry-tagged protein primarily on the
plasma membrane at levels comparable to wild-type TMEM16F.
Mass Spectrometry.
Protein identification using LC-MS/MS. WT MEFs, B16F10, and BV2 cells were
induced to produce GPMVs using 25 mM PFA and 2 mM DTT in GPMV buffer
(10 mM Hepes, 150 mM NaCl, 2 mM CaCl2) for 1.5 h at 37 °C. Following in-
cubation, supernatants from each flask were decanted into conical tubes,
centrifuged at 500 × g for 5 min to clear cells and large debris, and ultra-
centrifuged at 100,000 × g for 30 min to pellet vesicles. Platelets were pre-
pared from WT C57Bl6 mice using previously described methods (16). Purified
platelets were resuspended in Ca2+-free Tyrode’s Hepes buffer [134 mM NaCl,
12 mM NaHCO3, 2.9 mM KCl, 0.34 mM NaHPO4, 1.0 mMMgCl2, 10 mM Hepes,
0.9% wt/vol dextrose, and 0.35% wt/vol BSA (pH 7.4)] and induced to produce
microvesicles using 1 μM calcium ionophore A23187 (Sigma) in the presence of
2 mM CaCl2 for 1 h at 37 °C. Following incubation, platelets were pelleted at
500 × g at room temperature, and the vesicles contained in the supernatant
were ultracentrifuged at 100,000 × g for 30 min. Pelleted vesicles were
resuspended using 1× LDS (lithium dodecyl sulfate) sample buffer, run on a 4–
12% NuPAGE gradient gel (Thermo Fisher), and stained with colloidal Coo-
massie. In total 19 bands were excised from the colloidal Coomassie-stained
SDS gel and subjected to in-gel tryptic digestion. The proteins in the gel bands
were reduced with 10 mM DTT (Sigma-Aldrich) at 56 °C for 1 h, followed by
alkylation with 55 mM iodoacetamide (Sigma) at room temperature in the
dark for 45 min. The samples were then incubated overnight at 37 °C with
100 ng trypsin (sequence grade; Promega). The peptides formed from the
digested proteins were then analyzed by online liquid chromatography with
tandem mass spectrometry (LC-MS/MS). The LC separation was performed
using a nanoACQUITY UPLC system (Waters) on an Easy-Spray PepMap column
(75 μm × 15 cm; Thermo Fisher) over a 60-min chromatogram running time.
The linear gradient started from 2% buffer B (0.1% formic acid in acetonitrile)
and was increased to 30% buffer B at a flow rate of 300 nL/min. The MS/MS
analysis was conducted with a LTQ Orbitrap Velos mass spectrometer (Thermo
Fisher) and was performed using a top six data-dependent acquisition. The
sequence includes one survey scan in the Orbitrap with mass resolution of
30,000 followed by six collision-induced dissociation scans in the linear ion
trap. The analytical peak lists were generated from the raw data using in-
house software, PAVA (48). The MS/MS data were searched against the
UniProt mouse database using an in-house search engine, Protein Prospector
(prospector.ucsf.edu/prospector/mshome.htm).
Gene ontology analysis. AmiGO 1.8 (49–51) was used to generate a list of ex-
tracellular vesicle-related genes under the category “extracellular exosome”
(GO: 0070062), and the MGI identifiers were converted to UniProKB IDs to
analyze the enrichment of EV-related proteins in our proteomics experiments.
Western Blotting. Cultured cells were washed twice in Dulbecco’s PBS (DPBS),
scraped into 1 mL DPBS, and centrifuged at 1,000 × g for 5 min. Cell pellets
were resuspended and lysed in radioimmunoprecipitation assay buffer (50 mM
Tris, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS)
with 1 mM PMSF and 1 mM tris(2-carboxyethyl)phosphine. Whole-cell lysate
was then diluted in 4× LDS sample buffer (10 μg loaded for Fig. 1B, 2 μg for
Fig. 2C) and resolved on a 4–12% NuPAGE gradient gel, transferred to 0.2 μm
nitrocellulose membrane using a semidry blotter, blocked for 1 h in 5%milk in
TBST (tris-buffered saline and Tween 20) (20 mM Tris, 150 mM NaCl, 0.1%
Tween-20), and incubated overnight in primary antibody in 2% milk in TBST.
On the next day, blots were washed three to five times in ddH2O and once in
TBST, incubated with HRP-conjugated secondary antibody, washed three times
in TBST, and developed with ECL imaged using a Li-Cor C-digit scanner. Pri-
mary antibodies used in this study were 1:500 rabbit polyclonal α-TMEM16F
(16), 1:1,000 chicken polyclonal α-mCherry (Abcam), and 1:2,000 mouse
monoclonal α-tubulin (Sigma). Secondary antibodies used in this study were
1:20,000 goat anti-rabbit-HRP (Thermo Fisher), 1:20,000 goat anti-chicken-HRP
(Thermo Fisher), and 1:20,000 donkey anti-mouse-HRP (Jackson ImmunoResearch).
Microscopy.
Confocal imaging. The 16F- and mCh-cyto-expressing stable HEK293 cells were
incubated with lentivirus to express EGFP-PH-PLCδ 36–48 h before imaging.
Cells were plated in glass-bottom dishes coated with 1× poly-L-lysine (Sigma)
and 1:2,000 Matrigel (Sigma) 2 h before imaging.
GPMV generation assay. In only SI Appendix, Fig. S1, preincubation with
1:1,000 Cell Trace CFSE (Thermo Fisher), a nonspecific green fluorescent dye,
was used to facilitate visualization. Cultured cells were incubated with NucBlue
Live Cell Stain (Thermo Fisher) for 10 min, washed twice in DPBS, and treated
with 25 mM PFA/2 mM DTT in GPMV buffer (10 mM Hepes, 150 mM NaCl,
2 mM CaCl2) for live cell imaging on a Nikon-TE2000 Inverted Scope (Nikon
Instruments) equipped with a thermostat chamber. Images were acquired
once every minute starting 10 min posttreatment for 50 min for a total of 1 h
of treatment time. Quantification of the number of GPMVs in each frame was
collected using custom software (see GPMV Quantification for more detail).
Images of nuclear staining were acquired after each experiment and were
used to quantify the number of cells in each field for normalization purposes.
pSIVA scrambling assay. Cultured cells were incubated with NucBlue Live Cell
Stain for 10 min, washed twice in DPBS, and incubated in calcium-free GPMV
buffer (10 mMHepes, 150 mMNaCl, 0.1 mM EGTA) and 1:200 pSIVA (BioRad).
Image acquisition began once PFA/DTT/CaCl2 was added to a final concen-
tration of 25 mM/2 mM/2 mM and terminated after 1 h. Image analysis was
carried out on each individual cell using the Nikon Elements software.
Calcium flux assay. Cells were preloaded with 5 μM calcium indicator dye Fluo-
5N (Thermo Fisher) for 15 min at 37 °C and washed twice in DPBS before
GPMV induction.
Curve Fitting and Statistics. To calculate the values for Vmax, time of onset,
and duration, we fit the GPMV quantification data, pSIVA imaging data, or
Fluo-5N imaging data with the Weibull growth model using GraphPad Prism
7: Y =YM− ðYM−Y0Þ · expð−1ðk · xÞgÞ. YM is the maximum Y value. Y0 is the
Y value when x (time) is zero. k is the rate constant. Vmax is defined as the
maximum of the first derivative of this curve, time of onset is the maximum
of the second derivative (indicating the maximal acceleration of vesiculation,
PS exposure, or calcium rise), and duration is the difference between the
maximum and minimum of the second derivative. In all cases, data are
represented as mean ± SD except for PS exposure, which is represented as
mean ± SEM. Statistical significance was determined by one-way ANOVA
followed by a Holm–Sídák multiple comparisons test.
GPMV Quantification. GPMVs were counted using a custom Python code that
employs a combination of a Canny edge detection algorithm (52, 53) and a
convolutional neural net designed using lasagne and nolearn (54, 55). The
Canny edge detection was combined with a modified Hough transform to
detect circles in each image. The convolutional neural net was trained on 32 ×
32 pixel images of centered vesicles. Over 1,400 images were selected manually
to train the neural net, and these images were not included in the final analysis.
To increase the specificity of detection, a particular vesicle was counted only if
both the edge detection algorithm and neural net detected the vesicle.
Nanoparticle Tracking Analysis. Cells were washed twice with DPBS and then
incubated with 3 μM calcium ionophore A23187 (Sigma) in calcium-free buffer
(10mMHepes, 140 mMNaCl, 4 mMKCl, 1 mMMgCl2, 10mMdextrose, 0.1 mM
EGTA) for 5 min at room temperature. Cells were then washed with DPBS twice
and incubated in calcium-containing buffer (10 mMHepes, 140mMNaCl, 4 mM
KCl, 2 mM CaCl2, 1 mMMgCl2, 10 mM dextrose, 0.1 mM EGTA) for 1 h at 37 °C.
Supernatants from stimulated cells were collected and centrifuged for 500 × g
for 5 min, decanted into fresh tubes, and centrifuged at 2,000 × g for 20 min.
Extracellular vesicle concentration (EV mL−1) was determined by nanoparticle
tracking analysis (NTA), using a NanoSight LM10 instrument configured with a
complementary metal-oxide semiconductor camera and blue 408-nm laser
(Malvern Instruments). Videos were recorded five times for each sample, at 60 s
each, using a pump flow rate of 40 AU and controlled temperature of 22 °C. All
analysis was performed using NTA v3.2 software.
HomologyModeling. The TMEM16F homologymodel was generated using both
the open nhTMEM16 (PDB 4WIS) and TMEM16A (PDB 5OYB) as templates (11,
13). Sequence alignments were first done for nhTMEM16 and all mammalian
TMEM16 sequences using PROMALS3D (56). Using these sequence alignments
and template structures, the homology model was generated using MODELER
9.15 (57). A total of 300 models were generated, and the model with the
lowest discrete optimized protein energy (58) was selected.
Electrophysiology. Coverslips with cells were transferred to a recording chamber
on a Nikon-TE2000 Inverted Scope (Nikon), and transfection was confirmed with
fluorescent microscopy. Patch borosilicate pipets (Sutter Instrument) were pulled
from a Sutter P-97 puller with resistances of 2–3 MΩ for inside-out patch re-
cordings. Solutions were puffed to the excised patch using a VC3-8xP pressur-
ized perfusion system (ALA Science). The bath solution contained 145 mM NaCl,
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10 mM Hepes, 2 mM CaCl2, 1 mM MgCl2, and 10 mM glucose, pH 7.2 with
NaOH. The pipette solution contained 150 mMNaCl, 10 mMHepes, and 1 mM
CaCl2. The membrane patch for inside-out recording was excised in Ca
2+-free
solution to prevent desensitization (17): 150 mM NaCl, 10 mM Hepes, and
2 mM EGTA. For solutions with Ca2+ < 100 μM, Ca2+ was added to solutions
containing 2 mM hydroxyethylethylenediaminetriacetic acid, and the final
concentration was confirmed with Oregon Green BAPTA-5N (Thermo Fisher).
The osmolality of each solution was adjusted to 290–310 mOsm/kg. Data were
acquired using a Multiclamp 700B amplifier controlled by Clampex 10.2 via
Digidata 1440A (Axon Instruments). All experiments were performed at room
temperature (22–24 °C). All data were analyzed using pClamp10 (Molecular
Devices), OriginLab (OriginLab Corporation), and GraphPad Prism. For the
measurement of Ca2+ sensitivity, every trace was fit with the Hill equation
to generate its respective EC50 and H (Hill coefficient). The curves in the fig-
ures display the averaged current magnitudes normalized to their respective
maximal values (I/Imax %). Significant differences for EC50s of Ca
2+ response
curves were determined with Kruskal–Wallis tests followed by Dunn’s multiple
comparison tests. In all cases, data represent mean ± SEM.
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